{"title":"Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments","authors":"","doi":"10.1002/pu.31133","DOIUrl":null,"url":null,"abstract":"<p>A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A systematic review and meta-analysis of approved and off-label medication treatments for alcohol use disorder has concluded that oral naltrexone and acamprosate have the strongest evidence for reducing alcohol consumption. Trials that directly compared naltrexone and acamprosate did not establish superiority of one of the medications.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
